269 related articles for article (PubMed ID: 21325866)
1. Negative anti-C1q antibody titers may influence therapeutic decisions and reduce the number of renal biopsies in systemic lupus erythematosus.
Moura CG; Mangueira CL; Cruz LA; Cruz CM
Nephron Clin Pract; 2011; 118(4):c355-60. PubMed ID: 21325866
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
[TBL] [Abstract][Full Text] [Related]
3. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
[TBL] [Abstract][Full Text] [Related]
4. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
5. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
[TBL] [Abstract][Full Text] [Related]
6. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
[TBL] [Abstract][Full Text] [Related]
7. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC; Zhou B; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis.
Yin Y; Wu X; Shan G; Zhang X
Lupus; 2012 Sep; 21(10):1088-97. PubMed ID: 22777943
[TBL] [Abstract][Full Text] [Related]
9. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
Potlukova E; Kralikova P
Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
[TBL] [Abstract][Full Text] [Related]
10. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
[TBL] [Abstract][Full Text] [Related]
11. Association between the presence of anti-C1q antibodies and active nephritis in patients with systemic lupus erythematosus.
Gargiulo Mde L; Gómez G; Khoury M; Collado MV; Suárez L; Álvarez C; Sarano J
Medicina (B Aires); 2015; 75(1):23-8. PubMed ID: 25637896
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares.
Matrat A; Veysseyre-Balter C; Trolliet P; Villar E; Dijoud F; Bienvenu J; Fabien N
Lupus; 2011 Jan; 20(1):28-34. PubMed ID: 20943718
[TBL] [Abstract][Full Text] [Related]
13. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
14. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis.
Moroni G; Radice A; Giammarresi G; Quaglini S; Gallelli B; Leoni A; Li Vecchi M; Messa P; Sinico RA
Ann Rheum Dis; 2009 Feb; 68(2):234-7. PubMed ID: 18718989
[TBL] [Abstract][Full Text] [Related]
15. Complement 1q (C1q) antibodies levels in sera of Egyptian patients with lupus nephritis.
Elshweikh SA; Elkhouly RM; Shaalan MM; Shorbagy SH
Egypt J Immunol; 2014; 21(2):49-59. PubMed ID: 25812352
[TBL] [Abstract][Full Text] [Related]
16. Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis.
Bigler C; Hopfer H; Danner D; Schaller M; Mihatsch MJ; Trendelenburg M
Nephrol Dial Transplant; 2011 Apr; 26(4):1220-8. PubMed ID: 20841491
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies as markers for detecting concurrent disease activity in systemic lupus erythematosus.
Ntali S; Karim MY
Transl Res; 2010 Dec; 156(6):317-9. PubMed ID: 21078492
[No Abstract] [Full Text] [Related]
18. Anti-C1q autoantibodies in lupus nephritis.
Sinico RA; Rimoldi L; Radice A; Bianchi L; Gallelli B; Moroni G
Ann N Y Acad Sci; 2009 Sep; 1173():47-51. PubMed ID: 19758131
[TBL] [Abstract][Full Text] [Related]
19. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
Mok CC; Ho LY; Leung HW; Wong LG
Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493
[TBL] [Abstract][Full Text] [Related]
20. Correlation between serum anti-C1q antibody levels and renal pathological characteristics and prognostic significance of anti-C1q antibody in lupus nephritis.
Cai X; Yang X; Lian F; Lin X; Liang M; Li J; Chen X; Liang L; Qin S; Fu J
J Rheumatol; 2010 Apr; 37(4):759-65. PubMed ID: 20194446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]